LATEST ARTICLES

Access & Prescribing (Australia & Global)

Federally Funded Study Explores Why More Older Adults Are Turning to Medicinal Cannabis

Gillian Jalimnson -
Access & Prescribing (Australia & Global)

White House Drug Czar Clarifies Medical Cannabis Rescheduling Does Not Broadly Legalize Cannabis

Steven Gothrinet -
Equities, Investment & Market Trends

Senator Tim Scott Highlights “Quandary” of Cannabis Banking Access, Citing Need for Federal Legalization

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Employer Medical Cannabis Reimbursement Gains Traction Amid Federal Rescheduling

Steven Gothrinet -
Equities, Investment & Market Trends

Virginia Cannabis Sales Legislation Awaits Governor’s Decision After Lawmakers Reject Amendments

Steven Gothrinet -
Global Regulatory Updates

US Hemp Farmers React to New Federal Hemp-Derived Product Regulation

Steven Gothrinet -
Access & Prescribing (Australia & Global)

South Carolina Senator Declares Medical Cannabis Access Legal Following Federal Rescheduling

Steven Gothrinet -
Cannabinoid Pharmacology

Understanding Cannabis Use Disorder: Evolving Perspectives on Dependency and High-THC Products

Gillian Jalimnson -
Access & Prescribing (Australia & Global)

Minnesota and Louisiana Legislatures Advance Therapeutic Psilocybin and Psychedelic Pilot Programs

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Global Review Maps Administrative Interventions Crucial for Antimicrobial Stewardship Programs

Steven Gothrinet -
1...353637...316Page 36 of 316

MOST POPULAR

Cannabinoid Pharmacology

Epidiolex A Cash Machine For GW Pharmaceuticals

Gillian Jalimnson -
GW Pharmaceuticals estimates its net product sales for 2020 to have reached approximately USD $526 million - and its cannabidiol medicine made up the...
Read more
Access & Prescribing (Australia & Global)

Australia’s TGA Green-Lights Cannabidiol Without A Prescription

Steven Gothrinet -
Australia's Therapeutic Goods Administration (TGA) has announced its final decision on down-scheduling certain cannabidiol (CBD) preparations to Pharmacist Only Medicines - available over the...
Read more
Cannabinoid Pharmacology

Ananda Scientific Opioid Use Disorder CBD Trial Update

Gillian Jalimnson -
Ananda Scientific has announced the first patient enrolled in its clinical trial evaluating a cannabidiol-based drug as an adjunctive treatment for Opioid Use Disorder.The...
Read more
Equities, Investment & Market Trends

USDA 2023 National Hemp Report Released

Gillian Jalimnson -
Total hemp production value in the USA saw an increase in 2023, up 18% from 2022 according to the USDA's latest National Hemp Report.Released...
Read more
Load more